All News

Penis Implants, Other Devices Help Improve Quality of Life Issues in Men Following Prostate Cancer Treatment

October 15th 2020, 6:00pm


Men may experience erectile dysfunction and incontinence after receiving treatment for prostate cancer. However, there are devices — like a penile prosthetic and artificial urinary sphincter — that can help control those side effects associated with treatment.

Actor Sterling K. Brown is the Face of ‘Survivorship Today’ Shedding Light on Life After Cancer

October 15th 2020, 1:30pm


Through Bristol Myers Squibb’s ‘Survivorship Today,’ Brown — a star of the TV series “This Is Us” — has been interviewing cancer survivors about their journeys and the kinds of support they need.

FDA Approves Keytruda for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma

October 15th 2020, 12:30pm


Data from the trial that led to the FDA approval demonstrated that Keytruda reduced the risk of progression or death in patients with relapsed or refractory classical Hodgkin lymphoma by 35%, compared to Adcetris.

Increased Coffee Consumption Associated With Improved Outcomes in Patients With Advanced or Metastatic Colorectal Cancer

October 14th 2020, 6:00pm


The average overall survival for patients who reported consuming four or more cups of coffee per day prior to trail enrollment was 39 months.

Exercise, Diet Can Boost Bone Health in Prostate Cancer

October 14th 2020, 3:00pm


Prostate cancer treatment can be detrimental to bone and muscle health, but an exercise regimen and healthy eating habits can help.

Mortality From COVID-19 Increases in Patients Receiving Systemic Cancer Treatments

October 14th 2020, 1:00pm


In an interview with CURE®, Dr. Trisha Wise-Draper discusses new findings that show an increased mortality risk for patients with cancer receiving systemic treatments who subsequently contracted COVID-19.

Dose-Dense Chemotherapy Improves Disease-Free Survival in HR+/HER2- Breast Cancer

October 13th 2020, 9:00pm


Researchers found that neoadjuvant chemotherapy with intense dose-dense Ellence (epirubicin), Taxol (paclitaxel), and Cytoxan (cyclophosphamide) (iddEPC) demonstrated significant disease-free survival benefits in the treatment of patients with HR+/HER2- breast cancer.

Patients, Visitors and Clinicians Can Stop the Spread of C. Diff on Cancer Units

October 13th 2020, 6:00pm


Everyone has a role to play in decreasing Clostridioides difficile infection rates on oncology units, recent research shows.

Recognizing Metastatic Breast Cancer Awareness Day

October 13th 2020, 3:00pm


For Metastatic Breast Cancer Awareness Day on Oct. 13, 2020, here’s a round-up of fast facts and the latest news and updates in this disease space.

New CAR-T Cell Therapy, Given with Keytruda, Is Safe and Effective in Treating Diffuse Large B Cell Lymphoma

October 13th 2020, 1:00pm


Combining the immunotherapy Keytruda with a CAR-T cell therapy that targets the proteins CD19 and CD22 generates complete responses with minimal side effects, results from an early study demonstrate.